Is low serum tocopherol in Wilson's disease a significant symptom?

Sanjib Sinha, Rita Christopher, G. R. Arunodaya, L. K. Prashanth, G. Gopinath, H. S. Swamy, A. B. Taly

Research output: Contribution to journalArticle

18 Citations (Scopus)

Abstract

Free radical mediated injury is increasingly recognized in many metabolic diseases including Wilson's disease (WD). Use of antioxidants as an adjunctive therapy in WD may have therapeutic significance. The aim of the study was to correlate serum levels of tocopherols with serum copper and ceruloplasmin and clinical status of these patients. Serum levels of tocopherol of were measured spectrophotometrically using the Emmerie-Engel reaction in 34 patients from a large cohort of WD being followed up at a tertiary care center. Majority of patients were male (M/F=23:11). The mean serum copper was 43.6±26.2 μg/dl (range=10-121 μg/dl) and serum ceruloplasmin was 5.6±5.5 mg/dl (range=0-30 mg/dl). The mean serum tocopherol level was 0.68±0.18 mg/dl (range=0.23-1.14 mg/dl) and compared to the control (1.07±0.17 mg/dl), nearly 59% of patients had decreased levels (p

Original languageEnglish
Pages (from-to)121-123
Number of pages3
JournalJournal of the Neurological Sciences
Volume228
Issue number2
DOIs
Publication statusPublished - Feb 15 2005

Fingerprint

Hepatolenticular Degeneration
Tocopherols
Serum
Ceruloplasmin
Copper
Metabolic Diseases
Tertiary Care Centers
Free Radicals
Antioxidants
Wounds and Injuries
Therapeutics

Keywords

  • Antioxidant
  • Correlation with other symptoms
  • Tocopherol
  • Wilson's disease

ASJC Scopus subject areas

  • Ageing
  • Clinical Neurology
  • Surgery
  • Developmental Neuroscience
  • Neurology
  • Neuroscience(all)

Cite this

Sinha, S., Christopher, R., Arunodaya, G. R., Prashanth, L. K., Gopinath, G., Swamy, H. S., & Taly, A. B. (2005). Is low serum tocopherol in Wilson's disease a significant symptom? Journal of the Neurological Sciences, 228(2), 121-123. https://doi.org/10.1016/j.jns.2004.10.017

Is low serum tocopherol in Wilson's disease a significant symptom? / Sinha, Sanjib; Christopher, Rita; Arunodaya, G. R.; Prashanth, L. K.; Gopinath, G.; Swamy, H. S.; Taly, A. B.

In: Journal of the Neurological Sciences, Vol. 228, No. 2, 15.02.2005, p. 121-123.

Research output: Contribution to journalArticle

Sinha, S, Christopher, R, Arunodaya, GR, Prashanth, LK, Gopinath, G, Swamy, HS & Taly, AB 2005, 'Is low serum tocopherol in Wilson's disease a significant symptom?', Journal of the Neurological Sciences, vol. 228, no. 2, pp. 121-123. https://doi.org/10.1016/j.jns.2004.10.017
Sinha, Sanjib ; Christopher, Rita ; Arunodaya, G. R. ; Prashanth, L. K. ; Gopinath, G. ; Swamy, H. S. ; Taly, A. B. / Is low serum tocopherol in Wilson's disease a significant symptom?. In: Journal of the Neurological Sciences. 2005 ; Vol. 228, No. 2. pp. 121-123.
@article{403d3b41af864d94af74b90aa82f4477,
title = "Is low serum tocopherol in Wilson's disease a significant symptom?",
abstract = "Free radical mediated injury is increasingly recognized in many metabolic diseases including Wilson's disease (WD). Use of antioxidants as an adjunctive therapy in WD may have therapeutic significance. The aim of the study was to correlate serum levels of tocopherols with serum copper and ceruloplasmin and clinical status of these patients. Serum levels of tocopherol of were measured spectrophotometrically using the Emmerie-Engel reaction in 34 patients from a large cohort of WD being followed up at a tertiary care center. Majority of patients were male (M/F=23:11). The mean serum copper was 43.6±26.2 μg/dl (range=10-121 μg/dl) and serum ceruloplasmin was 5.6±5.5 mg/dl (range=0-30 mg/dl). The mean serum tocopherol level was 0.68±0.18 mg/dl (range=0.23-1.14 mg/dl) and compared to the control (1.07±0.17 mg/dl), nearly 59{\%} of patients had decreased levels (p",
keywords = "Antioxidant, Correlation with other symptoms, Tocopherol, Wilson's disease",
author = "Sanjib Sinha and Rita Christopher and Arunodaya, {G. R.} and Prashanth, {L. K.} and G. Gopinath and Swamy, {H. S.} and Taly, {A. B.}",
year = "2005",
month = "2",
day = "15",
doi = "10.1016/j.jns.2004.10.017",
language = "English",
volume = "228",
pages = "121--123",
journal = "Journal of the Neurological Sciences",
issn = "0022-510X",
publisher = "Elsevier",
number = "2",

}

TY - JOUR

T1 - Is low serum tocopherol in Wilson's disease a significant symptom?

AU - Sinha, Sanjib

AU - Christopher, Rita

AU - Arunodaya, G. R.

AU - Prashanth, L. K.

AU - Gopinath, G.

AU - Swamy, H. S.

AU - Taly, A. B.

PY - 2005/2/15

Y1 - 2005/2/15

N2 - Free radical mediated injury is increasingly recognized in many metabolic diseases including Wilson's disease (WD). Use of antioxidants as an adjunctive therapy in WD may have therapeutic significance. The aim of the study was to correlate serum levels of tocopherols with serum copper and ceruloplasmin and clinical status of these patients. Serum levels of tocopherol of were measured spectrophotometrically using the Emmerie-Engel reaction in 34 patients from a large cohort of WD being followed up at a tertiary care center. Majority of patients were male (M/F=23:11). The mean serum copper was 43.6±26.2 μg/dl (range=10-121 μg/dl) and serum ceruloplasmin was 5.6±5.5 mg/dl (range=0-30 mg/dl). The mean serum tocopherol level was 0.68±0.18 mg/dl (range=0.23-1.14 mg/dl) and compared to the control (1.07±0.17 mg/dl), nearly 59% of patients had decreased levels (p

AB - Free radical mediated injury is increasingly recognized in many metabolic diseases including Wilson's disease (WD). Use of antioxidants as an adjunctive therapy in WD may have therapeutic significance. The aim of the study was to correlate serum levels of tocopherols with serum copper and ceruloplasmin and clinical status of these patients. Serum levels of tocopherol of were measured spectrophotometrically using the Emmerie-Engel reaction in 34 patients from a large cohort of WD being followed up at a tertiary care center. Majority of patients were male (M/F=23:11). The mean serum copper was 43.6±26.2 μg/dl (range=10-121 μg/dl) and serum ceruloplasmin was 5.6±5.5 mg/dl (range=0-30 mg/dl). The mean serum tocopherol level was 0.68±0.18 mg/dl (range=0.23-1.14 mg/dl) and compared to the control (1.07±0.17 mg/dl), nearly 59% of patients had decreased levels (p

KW - Antioxidant

KW - Correlation with other symptoms

KW - Tocopherol

KW - Wilson's disease

UR - http://www.scopus.com/inward/record.url?scp=13444282362&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=13444282362&partnerID=8YFLogxK

U2 - 10.1016/j.jns.2004.10.017

DO - 10.1016/j.jns.2004.10.017

M3 - Article

VL - 228

SP - 121

EP - 123

JO - Journal of the Neurological Sciences

JF - Journal of the Neurological Sciences

SN - 0022-510X

IS - 2

ER -